CND Life Sciences: Funding, Investors & Team (Oct 2026)
CND Life Sciences is committed to supporting patients with neurodegenerative diseases, offering the Syn-One Test® as a first-of-its-kind tool to detect and measure misfolded phosphorylated alpha-synuclein in cutaneous nerve fibers. This test helps confirm synucleinopathies like Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and pure autonomic failure. The company operates a CLIA-certified and CAP-accredited lab in Scottsdale, AZ, providing a convenient and accurate alternative for diagnosis through skin biopsies. Additionally, CND collaborates with biopharmaceutical companies to advance research in the field.
CND Life Sciences has raised $28.1M across 7 funding rounds on record, the most recent a Private Equity announced in Aug 2026.
CND Life Sciences Company Profile and Key Stats
Latest funding round on record: Aug 2026.
CND Life Sciences Funding Rounds
1 of 7 rounds was announced without a disclosed amount and is excluded from the total.
CND Life Sciences raised $2.4M in a Grant announced in May 2022.
5 months later, a Grant of $3.0M was announced in Oct 2022.
1.4 years later, an undisclosed round of $2.0M was announced in Mar 2024.
8 months later, an undisclosed round of $4.2M was announced in Nov 2024.
6 months later, a Series A of $13.5M was announced in May 2025.
5 months later, an undisclosed round of $3.0M was announced in Oct 2025.
10 months later, a Private Equity was announced in Aug 2026 with no disclosed amount.
CND Life Sciences Investors
16 investors are recorded in total; the 5 named above are those the record identifies.
CND Life Sciences Founders and Leadership Team
Contact details for the CND Life Sciences team: 5 of 5 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →CND Life Sciences Funding Compared to Other Biotechnology Startups
Funded Startups Like CND Life Sciences in Biotechnology and Scottsdale
Companies Similar to CND Life Sciences
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
CND Life Sciences Funding FAQs
What does CND Life Sciences do?
CND Life Sciences is committed to supporting patients with neurodegenerative diseases, offering the Syn-One Test® as a first-of-its-kind tool to detect and measure misfolded phosphorylated alpha-synuclein in cutaneous nerve fibers. This test helps confirm synucleinopathies like Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and pure autonomic failure. The company operates a CLIA-certified and CAP-accredited lab in Scottsdale, AZ, providing a convenient and accurate alternative for diagnosis through skin biopsies. Additionally, CND collaborates with biopharmaceutical companies to advance research in the field.
How much funding has CND Life Sciences raised?
CND Life Sciences has raised $28.1M across 7 rounds on record.
When did CND Life Sciences last raise funding?
CND Life Sciences' most recent funding round on record was announced in Aug 2026. The amount was not disclosed.
Who has invested in CND Life Sciences?
Investors on record for CND Life Sciences include Michael J. Fox Foundation, LabCorp, MBX Capital, National Institutes of Health, BlueStone Venture Partners. FundedIQ records 16 investors in total.
Who founded CND Life Sciences?
FundedIQ lists Christopher Gibbons (Founder), Roy Freeman (Founder), Todd Dylan Levine (Founder) at CND Life Sciences.
Who is the CEO of CND Life Sciences?
Rick Morello is listed as Chief Executive Officer at CND Life Sciences.
Where is CND Life Sciences headquartered?
CND Life Sciences is based in Scottsdale, Arizona, United States.
How many employees does CND Life Sciences have?
CND Life Sciences is in the 11-50 employee band.
When was CND Life Sciences founded?
CND Life Sciences was founded in 2017.
About FundedIQ's CND Life Sciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for CND Life Sciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.